Robert Wenslow

Title: The Innovations of Robert Wenslow

Introduction

Robert Wenslow is an accomplished inventor based in Cranbury, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for various health conditions. His work focuses on innovative methods and formulations that address critical health issues.

Latest Patents

Wenslow holds a patent for "Crystalline and liquid crystalline 25-hydroxy-cholest-5-en-3-sulfate sodium and methods for preparing same." This patent describes the crystalline and liquid crystalline forms of 25HC3S sodium, including Forms I, II, III, V, IX, XI, and XIII, along with their combinations. The patent also details pharmaceutical formulations of these forms and methods for treating or preventing diseases such as hypercholesterolemia, hypertriglyceridemia, and conditions related to fat accumulation and inflammation, including non-alcoholic fatty liver disease (NAFLD) and atherosclerosis. Additionally, methods for preparing 25HC3S are provided.

Career Highlights

Wenslow is associated with Medicis Pharmaceutical Corporation, where he has been instrumental in advancing pharmaceutical innovations. His expertise in the field has led to the development of effective treatments that have the potential to improve patient outcomes.

Collaborations

Wenslow has collaborated with notable colleagues, including Andrew R Miksztal and Shawn Johnstone. These partnerships have contributed to the successful development of his patented innovations.

Conclusion

Robert Wenslow's contributions to pharmaceutical innovations demonstrate his commitment to improving health outcomes through scientific advancements. His work continues to impact the field positively, showcasing the importance of innovation in medicine.